Beta1 integrin inhibition dramatically enhances radiotherapy efficacy in human breast cancer xenografts.
about
β1 integrin targeting potentiates antiangiogenic therapy and inhibits the growth of bevacizumab-resistant glioblastomaIdentifying and targeting tumor-initiating cells in the treatment of breast cancerβ1 and β4 integrins: from breast development to clinical practiceA computer-assisted 3D model for analyzing the aggregation of tumorigenic cells reveals specialized behaviors and unique cell types that facilitate aggregate coalescenceThe development and characterization of a human mesothelioma in vitro 3D model to investigate immunotoxin therapyCoadministration of the FNIII14 Peptide Synergistically Augments the Anti-Cancer Activity of Chemotherapeutic Drugs by Activating Pro-Apoptotic BimCaveolin-1: an essential modulator of cancer cell radio-and chemoresistanceControlled breast cancer microarrays for the deconvolution of cellular multilayering and density effects upon drug responsesHigh-throughput 3D screening reveals differences in drug sensitivities between culture models of JIMT1 breast cancer cellsWhy don't we get more cancer? A proposed role of the microenvironment in restraining cancer progressionβ₁Integrin/FAK/cortactin signaling is essential for human head and neck cancer resistance to radiotherapyLigand-induced Epitope Masking: DISSOCIATION OF INTEGRIN α5β1-FIBRONECTIN COMPLEXES ONLY BY MONOCLONAL ANTIBODIES WITH AN ALLOSTERIC MODE OF ACTION.Miniaturized pre-clinical cancer models as research and diagnostic tools.Integrins in development and cancer.Microenvironmental regulation of therapeutic response in cancerIntegration of biological knowledge and gene expression data for biomarker selection: FN1 as a potential predictor of radiation resistance in head and neck cancer.Beta1 integrins mediate cell proliferation in three-dimensional cultures by regulating expression of the sonic hedgehog effector protein, GLI1.Fibroblast heterogeneity in the cancer wound.PINCH1 regulates Akt1 activation and enhances radioresistance by inhibiting PP1alphaRAD9 enhances radioresistance of human prostate cancer cells through regulation of ITGB1 protein levels.beta1-integrin is dispensable for the induction of ErbB2 mammary tumors but plays a critical role in the metastatic phase of tumor progressionBreast cancer cells in three-dimensional culture display an enhanced radioresponse after coordinate targeting of integrin alpha5beta1 and fibronectin.HER2 signaling pathway activation and response of breast cancer cells to HER2-targeting agents is dependent strongly on the 3D microenvironment.Cell-matrix interactions in mammary gland development and breast cancerGenome-wide gene expression analysis in cancer cells reveals 3D growth to affect ECM and processes associated with cell adhesion but not DNA repair.The need for complex 3D culture models to unravel novel pathways and identify accurate biomarkers in breast cancerIdentification of a radiosensitivity signature using integrative metaanalysis of published microarray data for NCI-60 cancer cells.Somatic mutations favorable to patient survival are predominant in ovarian carcinomasPancreatic stellate cells radioprotect pancreatic cancer cells through β1-integrin signaling.A cell-ECM screening method to predict breast cancer metastasis.Metastasis Update: Human Prostate Carcinoma Invasion via Tubulogenesis.β1 integrin mediates an alternative survival pathway in breast cancer cells resistant to lapatinib.β1-integrins signaling and mammary tumor progression in transgenic mouse models: implications for human breast cancer.Cancer-associated fibroblasts from human NSCLC survive ablative doses of radiation but their invasive capacity is reduced.3D culture of Her2+ breast cancer cells promotes AKT to MAPK switching and a loss of therapeutic response.Focal adhesion-chromatin linkage controls tumor cell resistance to radio- and chemotherapySpecific β-containing integrins exert differential control on proliferation and two-dimensional collective cell migration in mammary epithelial cells.The mesenchymal tumor microenvironment: a drug-resistant niche.Expression of ITGB1 predicts prognosis in colorectal cancer: a large prospective study based on tissue microarrayDistinct effects of β1 integrin on cell proliferation and cellular signaling in MDA-MB-231 breast cancer cells.
P2860
Q24564890-01A1657E-A60E-45CC-9D26-2CC1F4B02A7BQ26851827-97903D76-2AA5-4825-AF7B-78DF3DF21A8EQ27000311-0727499A-9D54-447A-BD4D-26534BE58DB6Q27313571-163304CC-75D2-4943-90AE-0091F80AC3A5Q27314606-2E2587B5-2230-47A9-A96A-E08EFEE286CAQ27322913-FF025173-225A-4109-97DB-BBCB1892E555Q28392375-942AD3A6-3250-4638-9DFF-C9AF34E0554EQ28480895-4E6DCE94-7F95-4EF8-8B1D-F0D39B5A3EA5Q28534624-12B51BC6-C9E8-4E2B-8DC6-FBDD9A760CC3Q29614274-DD208099-0B40-41EA-88B8-E5C363543113Q30427521-C8CFC4E2-B596-4EBA-830C-A521B8F0AE7DQ30826108-0C85AEF4-C9D4-42C5-B2EE-8D448091FD6BQ33605145-7C651D4F-60F4-4DC2-A0BB-59D0FD0B1941Q33639648-71446675-F546-404B-A0EF-2A301F00CD42Q33654609-596F1A7D-84FA-48C2-9A97-A4ADFA37E211Q33719052-2352D4C8-B5B1-4C58-A234-A436D732A980Q33914011-6E035784-2E55-4071-9212-3F169EF156B5Q33964324-8FB6BEBF-F3CD-492E-AE49-2DA641850DBBQ33968025-5F9849A6-52A3-4E27-878A-B730C8F93682Q34079523-599DBAF4-C2DC-454F-9FDB-C0135BCF6979Q34100493-6FFFDA52-B646-43A4-B970-63D3403EF59EQ34103283-BFF5CF42-23BF-40D1-AA85-C364633914D5Q34111958-419D405F-F5B5-477E-BF2B-72EB0A352428Q34149916-B4205C19-7C62-45E0-8EF6-32278DC4EF48Q34235126-3C18DE51-D366-44D3-BDE3-8339C329820CQ34291977-09EAF6D9-FE8D-41C3-AEAC-4E836F9B74ABQ34356765-0361473A-157C-4BE7-AA5D-E91C95532656Q34497796-C77C0A13-4435-459F-9D58-1889C1AEFAAFQ34989886-4A293C95-D34C-4DDE-B66C-744A473703CCQ35070945-AE17EAA7-9EBB-496F-AE0D-5AA4D7DA56B0Q35225370-FC4E848A-E20B-4241-9F55-4245D40B922EQ35608736-2E62ED1E-3F61-47DD-B532-A21C1A3B530FQ35889538-D7108F0D-4E55-432B-8C91-136077D85057Q35984652-F7D3DD66-EAF0-4B4F-AC78-C8EABF00C3DFQ36037262-2ED7BAD3-7CDB-4292-8EA9-3800373B745EQ36065096-7D181BDC-5CE4-462A-AC51-A0F34B64ED5CQ36097899-A85C3218-7182-4BBF-A3BF-CA4297FD0F59Q36187755-B9D09C65-D7FC-459E-BC69-F29BE3374C65Q36375230-C8CF3212-26C9-4E6A-AE45-D41BC38AD3B0Q36427883-9D1981A1-95EC-4890-A496-6D136FC78287
P2860
Beta1 integrin inhibition dramatically enhances radiotherapy efficacy in human breast cancer xenografts.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Beta1 integrin inhibition dram ...... uman breast cancer xenografts.
@en
Beta1 integrin inhibition dram ...... uman breast cancer xenografts.
@nl
type
label
Beta1 integrin inhibition dram ...... uman breast cancer xenografts.
@en
Beta1 integrin inhibition dram ...... uman breast cancer xenografts.
@nl
prefLabel
Beta1 integrin inhibition dram ...... uman breast cancer xenografts.
@en
Beta1 integrin inhibition dram ...... uman breast cancer xenografts.
@nl
P2093
P2860
P1433
P1476
Beta1 integrin inhibition dram ...... uman breast cancer xenografts.
@en
P2093
Catherine C Park
Chong J Park
Evelyn S Yao
Hui J Zhang
Mina J Bissell
P2860
P304
P356
10.1158/0008-5472.CAN-07-6390
P407
P577
2008-06-01T00:00:00Z